静蕊品牌怎么样 申请店铺

我要投票 静蕊在女性洗液行业中的票数:230 更新时间:2025-02-23
静蕊是哪个国家的品牌?「静蕊」是普诺康医药科技(莱州)有限公司旗下著名品牌。该品牌发源于山东,由创始人杨奎敏在2018-11-07期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力静蕊品牌出海!通过在本页面挂载静蕊品牌的产品链接和联系邮箱,可以提高静蕊产品曝光!跨境电商爆单神器,目前只要100元/年哦~

静蕊怎么样

静蕊抗菌护理系列由普诺康倾情打造,堪称女性健康私护第一品牌,其核心成分“PVP-I”具有高效的杀菌作用,杀菌率高达99.76%,可以抑制阻断性生活中多种病原体交叉感染,修复粘膜,可以阻断和预防的细菌和病毒包括阴道毛滴虫、念球菌、大肠杆菌、淋球菌、甚至包括衣(支)原体、HPV、疱疹病毒等。长期使用可以修复和强化女性天然防御功能,预防妇科问题,还可以养卵美容,保持年轻美态。它的出现为女性私护产品开辟了新纪元。

静蕊抗菌护理系列凭借着诸多优势,一经投放市场,就因其非常好的使用效果和零副作用的特点得到了众多使用者的认可,很多人由患者变成了代理,对产品更信赖更有信心。

为什么静蕊抗菌护理系列能拥有如此的口碑?它的成分是什么?与市面同类私护产品的区别?且看下面详解。

静蕊抗菌护理系列的核心成分是“PVP-I”,“PVP-I”是唯一被列入多国药典、纳入《国家基本药物目录》、WHO世界卫生组织向全球推荐的消毒抗菌成分,“PVP-I”对于杀灭HPV病毒的作用得到知名专家教授认可。

市面上的所谓“抑菌”类私护产品,只能抑制细菌生长,不能真正做到杀菌;目前市面上的私护产品(包括洗液和凝胶)很多是采用中草药成份做成的,此类产品虽然价格便宜,但见效非常慢,使用周期很长;而见效快一点的纳米银类洗液使用过后,部分人可能过敏,并且容易造成重金属(银离子)在人体内的残留和堆积,国家卫生部门已有相应的安全提示。

而静蕊抗菌系列产品是“抗菌”产品,可以真正高效的杀灭细菌病毒;静蕊的精华成分是以超临界萃取技术萃取自源自北极冰海的深海藻类,更安全更天然;且静蕊拥有国家发明专利配方,使用独特载体,应用3大前沿科技技术(高分子聚合缓释技术、靶向定位技术、3D渗透技术),具有对皮肤黏膜无刺激、杀菌长效持久、高指向性、深层穿透清除更彻底的特点。

静蕊抗菌护理系列重视机体自身自愈功能,在抗菌同时通过提升私密机能改善私密问题,带动其它系统的健康态、年轻态,达到全身综合调理的目的,物理调理,不打针不吃药,安全省心!

有数据显示,每年都会有20--30多万的女性,因为妇科疾病失去了宝贵的生命,女性如果没有健康,就没有了一切。健康一个女人,幸福一个家庭,和谐一个社会。静蕊一再呼吁“防大于治”,希望每位女性朋友都能真正认识女性私护,对自己好一点,做一个健康、自信的女子。

Jingrui antibacterial care series is made by pronocon, which is the first brand of women's health private care. Its core component PVP-I has an efficient bactericidal effect, with a bactericidal rate of 99.76%. It can inhibit the interdiction of multiple pathogens cross infection in sexual life, repair the mucous membrane, and block and prevent bacteria and viruses including Trichomonas vaginalis, Candida, Escherichia coli, Neisseria gonorrhoeae It even includes chlamydia, HPV, herpesvirus, etc. Long term use can repair and strengthen women's natural defense function, prevent gynaecological problems, raise eggs for beauty, and keep young and beautiful. Its appearance has opened a new era for women's personal protection products. Jingrui antibacterial care series has many advantages. Once put on the market, it has been recognized by many users because of its very good use effect and zero side effects. Many people have become agents from patients, and have more confidence in the product. Why does Jingrui antibacterial care series have such a reputation? What are its ingredients? What's the difference between Jingrui antibacterial care series and the same kind of private care products on the market? Let's see the details below. The core component of Jingrui antibacterial nursing series is "PVP-I". PVP-I is the only disinfection antibacterial component listed in the Pharmacopoeia of many countries, included in the catalogue of national essential drugs, and recommended to the world by who. The role of PVP-I in killing HPV virus has been recognized by famous experts. The so-called "bacteriostatic" private protective products on the market can only inhibit the growth of bacteria, and can not really sterilize. At present, many private protective products (including lotions and gels) on the market are made of Chinese herbal ingredients. Although the products are cheap, the effect is very slow and the use cycle is very long. However, some people may be allergic to nano silver lotion which has a faster effect, and it is easy to cause heavy metal (silver ion) residue and accumulation in human body. The National Health Department has relevant safety tips. The antibacterial products of Jing Rui are antibacterial products, which can effectively kill bacteria viruses. The essence of Jing Rui is extracted from the deep-sea algae originating from the Arctic ice sea by supercritical fluid extraction technology, which is safer and more natural. Jingrui has a national patent formula, uses a unique carrier, and applies three cutting-edge technologies (polymer polymer slow-release technology, targeted positioning technology, 3D penetration technology), which has the characteristics of no stimulation to skin and mucosa, long-lasting sterilization, high directivity, and more thorough deep penetration and removal. Jingrui antibacterial nursing series attaches great importance to the self-healing function of the body, improves the privacy problem by improving the privacy function, drives the health and youth of other systems, achieves the purpose of comprehensive body conditioning, physical conditioning, no injection, no medicine, safety and worry! It has been shown that every year there are more than 200000-300000 women, because gynecological diseases lose their precious lives, If women don't have health, they don't have everything. A healthy woman, a happy family, a harmonious society. Jingrui has repeatedly called for "prevention is more important than cure", hoping that every female friend can really know women's personal protection and be a healthy and confident woman.

本文链接: https://brand.waitui.com/108c71fc0.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

上海市副市长陈杰:加快建设人工智能“上海高地”,壮大开源社区力量

36氪获悉,2月23日,2025全球开发者先锋大会在上海徐汇召开,上海市副市长陈杰出席开幕式并发表致辞。陈杰指出,面对人工智能快速迭代、模型开源的新趋势,上海将继续发挥超大城市的综合优势,加快建设更具国际影响力的人工智能“上海高地”。进一步完善开源开放生态系统,夯实“语料开放+模型开源”服务体系,不断壮大开源社区力量,推动基础模型、算法和数据资源的共享与开放,构建开放协作、互利共赢的创新环境。(中国基金报)

33分钟前

清华AIR联合水木分子开源DeepSeek版多模态生物医药大模型BioMedGPT-R1

36氪获悉,清华大学人工智能产业研究院(AIR)和北京水木分子生物科技有限公司近日携手推出了升级版的生物医药多模态开源基础大模型BioMedGPT-R1。此前,在2023年,双方合作发布了开源可商用、生物医药多模态百亿参数开源基础大模型BioMedGPT,水木分子发布了自研千亿参数多模态生物医药专业大模型Chat DD-FM和新一代AI驱动药物发现工具Chat DD。这次DeepSeek版ChatDD- R1基座模型也已同步上线ChatDD,赋能生物医药企业的药物研发。

33分钟前

TCL李东生:中国制造未来在海外最大增量大概率来自新兴市场

36氪获悉,TCL&奥林匹克全球合作伙伴签约仪式近日在北京举行。会后,TCL创始人、董事长李东生接受记者采访时表示,当前全球产业链面临转移与重构,持续由全球化向区域化、本土化方向发展。中国制造未来在海外最大的增量空间大概率来自新兴市场,比如巴西等新兴经济体。目前TCL海外制造基地分布在越南、马来西亚、菲律宾、印尼、印度、巴基斯坦、波兰、墨西哥、巴西等九个国家,实现东南亚、南亚、欧洲、北美、南美等各大区域本土化制造布局。未来,会持续关注新兴市场的增长潜力。

33分钟前

深圳:来深毕业生免费7天住升级为15天

为方便各地高校毕业生来深找工作,深圳相继推出“青年驿站”“深梦启航”“深梦扬帆”等“深梦”系列公益活动,为各地来深高校毕业生提供免费7天居住福利,解决他们阶段性、过渡性的居住需求。 2月23日,深圳市政府新闻办召开“打造最好科技创新生态和人才发展环境”新闻发布会。市委科创委办公室主任、科技创新局局长张林在会上透露,深圳为高校应届毕业生来深求职提供免费住宿天数,将从7天延长到15天。 (深圳特区报)

33分钟前

湖南规范互联网医院处方行为:严禁使用AI等自动生成处方

36氪获悉,湖南省医保局近日发布《关于进一步加强基本医疗保障定点零售药店管理的通知》。通知中提到,规范互联网医院处方行为。对互联网医院处方有如下几个措施:①压实实体医疗机构责任。依托实体医疗机构与市级医保部门签订补充协议,强化实体医疗机构的管理责任,因互联网医院违规被解除补充协议的原则上同步解除实体医疗机构医保定点协议,依托的实体医疗机构原则上应为二级及以上医疗机构。②纳入医保管理范畴。在本统筹区提供处方服务的由本市医保中心签协议后公布,跨市州提供处方服务的先征得药店所在地市级医保中心同意,再报省医保中心审定公布。③接入处方流转平台。互联网医院须按规定接入省医保电子处方中心并进行电子处方流转。④明确处方要求。处方行为必须符合行业主管部门管理办法,应与患者或患者家属进行有效、充分的沟通问诊,严禁使用人工智能等自动生成处方。

33分钟前

本页详细列出关于Primera芙莉美娜的品牌信息,含品牌所属公司介绍,Primera芙莉美娜所处行业的品牌地位及优势。
咨询